Two Genen­tech vets re­unite at Im­mune-Onc to help steer its $33M dri­ve to the clin­ic

Look for yet an­oth­er play­er work­ing in the im­muno-on­col­o­gy space to en­ter the clin­ic with a nim­ble team of ex­pe­ri­enced ex­ecs fo­cused on dis­man­tling im­muno­sup­pres­sion.

Pa­lo Al­to-based Im­mune-Onc an­nounced to­day that co-founder Char­lene Liao has wooed fel­low Genen­tech vets Adri­an Jubb and An Song to join her in prep­ping the start­up for first-in-hu­man stud­ies, fu­eled by $33 mil­lion in Se­ries B fund­ing. North­ern Light Ven­ture Cap­i­tal, Vi­vo Cap­i­tal and the Stan­ford-StartX Fund are tout­ed as the star in­vestors in the round.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER